Key Market Segments:
By Modality
-
Molecular Ultrasound Imaging
-
Positron Emission Tomography (PET)
-
Single Photon Emission Computed Tomography (SPECT)
-
Nuclear Magnetic Resonance (NMR) Spectrometer
-
Other Modalities
By Application
-
Cardiovascular
-
Neurology
-
Oncology
-
Respirator
-
Gastrointestinal
By End-use
-
Hospitals
-
Diagnostic Imaging Centers
-
Research Institutes
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
-
US
-
Canada
-
Mexico
Europe
-
Eastern Europe
-
Poland
-
Romania
-
Hungary
-
Turkey
-
Rest of Eastern Europe
-
-
Western Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Netherlands
-
Switzerland
-
Austria
-
Rest of Western Europe
-
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Vietnam
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
Middle East
-
UAE
-
Egypt
-
Saudi Arabia
-
Qatar
-
Rest of the Middle East
-
-
Africa
-
Nigeria
-
South Africa
-
Rest of Africa
-
Latin America
-
Brazil
-
Argentina
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Product Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Product Matrix which gives a detailed comparison of product portfolio of each company
-
Geographic Analysis
-
Additional countries in any of the regions
-
Company Information
-
Detailed analysis and profiling of additional market players (Up to five)
Frequently Asked Questions
Ans:
- Significant capital investment, along with operational and maintenance expenses, can limit accessibility, especially in resource-constrained settings and smaller healthcare facilities.
- Inadequate coverage for molecular imaging procedures and radiopharmaceuticals creates uncertainties for healthcare providers, hindering widespread adoption of these technologies.
Ans: The major key players in the market are GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems Corporation, Elekta AB, Medtronic, Thermo Fisher Scientific, PerkinElmer, Invivo (a part of Philips), Hitachi Medical Systems, and others in the final report.
Ans. The CAGR of the Molecular Imaging Market is 4.5% During the forecast period of 2024-2032.
Ans: The North American region dominated the Molecular Imaging Market in 2023.
Ans. The projected market size for the Molecular Imaging Market is USD 12.5 Billion by 2032.